I now have excellent textbook content. Let me build the perfect exam answer.
Tumor Markers
Biochemistry - 1st Year MBBS | 5 Marks Question
DEFINITION
A tumor marker is a substance (protein, hormone, enzyme, or antigen) that is produced by cancer cells or by the body in response to cancer, and can be detected in the blood, urine, or tissue.
Simple way to remember: Tumor markers are like "clues" in the blood that tell us a cancer is present or growing.
IMPORTANT POINTS TO KNOW
- Tumor markers are NOT used alone to diagnose cancer (they are not 100% accurate)
- They are most useful for:
- Monitoring treatment - if treatment is working, the marker level falls
- Detecting recurrence - if cancer comes back after treatment, the marker rises again
- Screening (in some cases, e.g., PSA for prostate cancer)
- They can also be raised in non-cancerous (benign) conditions -- this is their main limitation
CLASSIFICATION OF TUMOR MARKERS
Tumor markers are classified into 5 groups based on their type:
1. Oncofetal Antigens
These are proteins normally made during fetal development (in the baby inside the womb). After birth they disappear. But in cancer, they reappear in the blood.
| Marker | Cancer | Normal value |
|---|
| AFP (Alpha-Fetoprotein) | Liver cancer (hepatocellular carcinoma), testicular germ cell tumors, yolk sac tumors | < 10 ng/mL |
| CEA (Carcinoembryonic Antigen) | Colorectal (colon) cancer, pancreatic, stomach, lung, breast cancer | < 2.5 ng/mL |
Memory trick: AFP = Alpha Fetal Protein = liver/testis cancer. CEA = Colon cancer (and others)
2. Hormones
Some cancers produce hormones that are not normally produced by that tissue.
| Marker | Cancer |
|---|
| hCG (Human Chorionic Gonadotropin) | Testicular tumors (non-seminomatous), trophoblastic tumors (choriocarcinoma) |
| Calcitonin | Medullary carcinoma of thyroid |
| Catecholamines (in urine) | Pheochromocytoma (adrenal gland tumor) |
3. Enzymes
Enzymes released by cancer cells in abnormally high amounts.
| Marker | Cancer |
|---|
| PSA (Prostate-Specific Antigen) | Prostate cancer |
| Acid Phosphatase | Prostate cancer (older marker, now replaced by PSA) |
| LDH (Lactate Dehydrogenase) | Lymphoma, leukemia, testicular cancer |
| Alkaline Phosphatase | Bone metastasis, liver cancer |
PSA in Detail (Very Important!):
- PSA is the most widely used tumor marker in clinical practice
- It is a protein produced by the prostate gland
- Elevated PSA suggests prostate cancer
- BUT: PSA can also be raised in benign prostatic hyperplasia (BPH) and prostatitis
- So PSA has low sensitivity and low specificity
- PSA is most useful to monitor for recurrence after prostate cancer surgery
4. Mucins / Glycoproteins (CA Antigens)
"CA" = Cancer Antigen
| Marker | Cancer |
|---|
| CA-125 | Ovarian cancer (also fallopian tube, colon cancer) |
| CA-19-9 | Pancreatic cancer, colorectal cancer, hepatobiliary cancer |
| CA-15-3 | Breast cancer |
| CA-72-4 | Gastric (stomach) cancer |
Memory trick: CA-125 = 125 ovaries (ovarian cancer). CA-19-9 = Pancreas (think 19-9 = pancreatitis-like number)
5. Immunoglobulins (Proteins)
| Marker | Cancer |
|---|
| Monoclonal Immunoglobulin (M-protein / Bence Jones protein in urine) | Multiple myeloma, other plasma cell tumors |
IDEAL TUMOR MARKER - PROPERTIES
An ideal tumor marker should be:
- Produced only by cancer cells (high specificity)
- Detectable even in early/small cancers (high sensitivity)
- Easy to measure in blood/urine
- Level should rise and fall with disease activity
Unfortunately, no tumor marker is perfect yet! All have some limitations.
USES OF TUMOR MARKERS (Clinical Applications)
| Use | Example |
|---|
| Diagnosis (screening) | PSA for prostate cancer screening |
| Monitoring treatment response | CEA falls after successful colon cancer surgery |
| Detecting recurrence | AFP rises again if liver cancer comes back |
| Staging and prognosis | High AFP = more aggressive tumor |
| Identifying tumor type | AFP = liver/testicular; hCG = testicular/trophoblastic |
LIMITATIONS OF TUMOR MARKERS
- Not specific - can be elevated in benign (non-cancerous) conditions
- PSA raised in BPH
- CEA raised in smokers, liver disease, inflammatory bowel disease
- AFP raised in cirrhosis, hepatitis
- Not sensitive - cancer can be present even with normal marker levels
- Cannot be used alone for diagnosis - always combined with clinical exam, imaging, and biopsy
MASTER SUMMARY TABLE (Quick Revision)
| Tumor Marker | Type | Cancer |
|---|
| AFP | Oncofetal antigen | Liver cancer, testicular tumor |
| CEA | Oncofetal antigen | Colon, pancreas, stomach, breast cancer |
| PSA | Enzyme/protein | Prostate cancer |
| hCG | Hormone | Testicular tumor, choriocarcinoma |
| Calcitonin | Hormone | Medullary thyroid carcinoma |
| CA-125 | Glycoprotein | Ovarian cancer |
| CA-19-9 | Glycoprotein | Pancreatic cancer |
| CA-15-3 | Glycoprotein | Breast cancer |
| LDH | Enzyme | Lymphoma, leukemia |
| M-protein | Immunoglobulin | Multiple myeloma |
| Catecholamines | Hormone | Pheochromocytoma |
KEY EXAM POINTS
- Tumor markers are found in blood/urine/tissue
- Main use = monitoring treatment & detecting recurrence (NOT primary diagnosis)
- PSA = prostate cancer (most widely used)
- AFP = liver + testicular cancer
- CEA = colon cancer (also pancreas, stomach, breast)
- hCG = testicular tumor + choriocarcinoma
- CA-125 = ovarian cancer
- CA-19-9 = pancreatic cancer
- All markers have a limitation - they can be raised in non-cancerous conditions too
- If marker disappears after treatment and reappears later = cancer has recurred
Sources: Robbins & Kumar Basic Pathology; Robbins, Cotran & Kumar Pathologic Basis of Disease
Write this in the exam with clear headings, the definition, the classification table, and the master summary table at the end. Your sir will be very impressed! All the best for your HNGU exams! 🎓